Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cole Hladik
Institutions:
OU Health,
University of Oklahoma Health Sciences Center,
University of Oklahoma
Observed institutions:
OU Health,
University of Oklahoma Health Sciences Center,
University of Oklahoma
ORCID:
0009-0007-2722-7247
Observed ORCID:
0009-0007-2722-7247
OpenAlex ID:
A5111262175
Comparison of Methods for Isolation and Characterization of Total and Astrocyte‐Enriched Extracellular Vesicles From Human Serum and Plasma
2025
·
Leandra K. Figueroa‐Hall
, Kaiping Burrows
, et al.
·
Journal of Extracellular Biology
·
18
PDF
Preferential release of microRNAs via extracellular vesicles is associated with ductal carcinoma in situ to invasive breast cancer progression
2025
·
Sugantha Priya Elayapillai
, Samrita Dogra
, et al.
·
Cancer Letters
·
8
Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer
2024
·
Sugantha Priya Elayapillai
, Anjalika Gandhi
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
4
Quantification of EV-associated miRNA in liquid biopsies for biomarker signature development
2026
·
Mia S. C. Yu
, Christian Grätz
, et al.
·
Extracellular Vesicles and Circulating Nucleic Acids
·
3
PDF
Spatially Resolved Obesity-Driven Molecular Changes in Early Breast Cancer
2026
·
Cole Hladik
, Malika Sekhri
, et al.
·
American Journal Of Pathology
·
3
Nanoluciferase-CD63 labeling reveals extracellular vesicle kinetics in a mouse intraductal model of ductal carcinoma in situ
2026
·
Cole Hladik
, Sugantha Priya Elayapillai
, et al.
·
Breast Cancer Research
·
2
DCLK1 regulates stemness and IL-6/STAT3–dependent metastatic niche formation in chemoresistant ovarian cancer
2026
·
Samrita Dogra
, Sugantha Priya Elayapillai
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
1
Comparative Evaluation of L1CAM, NCAM, and ATP1A3 for Enrichment and Characterization of Neuron-Enriched Extracellular Vesicles from Human Plasma and Serum
2026
·
Kaiping Burrows
, Leandra Figueroa-Hall
, et al.
PDF
DCLK1 regulates stemness and IL-6/STAT3–dependent metastatic niche formation in chemoresistant ovarian cancer
2026
·
Samrita Dogra
, Sugantha Priya Elayapillai
, et al.
·
Figshare
Characterization of the tumor immune microenvironment in a syngeneic orthotopic mouse model of endometrial carcinoma: a pilot study
2026
·
Nicole Minalt
, Saeede Soleimanian
, et al.
·
Gynecologic Oncology
Abstract 6647: Targeting DCLK1-mediated glutamine addiction in chemoresistant ovarian cancer
2025
·
Samrita Dogra
, Cole Hladik
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
39
H-index:
3
I10-index:
1
Year
Topic
Type